Understanding Uterine Fibroids: A Comprehensive Guide

Understanding Uterine Fibroids: A Comprehensive Guide

Millions of women worldwide suffer from uterine fibroids, a condition that remains a mystery to many. Whether symptoms are obvious or hidden from sight, fibroids can significantly impact a woman’s health and quality of life. This guide unpacks the world of uterine fibroids, from causes and symptoms to the latest treatment options available today.

[Insert a hopeful, sophisticated image here, like women supporting each other or an artistic representation of healing.]

What Are Uterine Fibroids?

Uterine fibroids, also known as myomas, are noncancerous growths that develop in the muscular wall of the uterus. They are composed of smooth muscle and fibrous tissue and are usually surrounded by a pseudocapsule that separates them from normal uterine muscle.

Fibroids are strongly influenced by hormones and age, most commonly appearing in women between 30 and 40 years old. Because they depend on estrogen and progesterone, they often shrink and cause fewer symptoms after menopause. Importantly, fibroids are rarely cancerous.

How Fibroid Location Affects Your Body

The location of fibroids plays a major role in how they affect the body.

The type and location of a fibroid determine the symptoms a woman might experience. The main types include:

• Subserosal and Intramural Fibroids: These grow on the outer wall of the uterus and can enlarge it considerably—sometimes to the size of a watermelon. These growths can cause abdominal pressure, frequent urination, constipation, or pain during intercourse.
• Submucosal Fibroids: These fibroids extend into the uterine cavity. They are the most significant type for causing heavy menstrual bleeding and anemia.

[Insert the diagram of fibroid types from the article here. Caption: “Illustration showing the different locations of uterine fibroids, including subserosal, intramural, and submucosal types.”]

Prevalence and Key Risk Factors

Fibroids are extremely common. In the United States, about 70% of women will develop them during their lifetime, with the highest prevalence seen between the ages of 50 and 54.

Certain populations are disproportionately affected. Up to 80% of African American women will develop fibroids compared to around 40% of Caucasian women. Indian women also show high rates of fibroid development. Globally, rates vary widely, with Eastern European countries reporting some of the highest numbers.

Several factors increase the likelihood of developing fibroids:

• Race: African American women are at the greatest risk.
• Age: Being older and premenopausal.
• Family History: Having a family member with fibroids.
• Other Health Conditions: Hypertension and obesity are linked to higher incidence.

Conversely, certain factors like the use of oral contraceptives, especially when started after adolescence, can lower the risk.

Common Symptoms of Uterine Fibroids

Fibroid symptoms vary widely but often include:

• Heavy or Prolonged Menstrual Bleeding: This is one of the most common complaints and can lead to anemia, fatigue, weakness, and even fainting.
• Abdominal Pressure and Distension: Large fibroids can make the abdomen appear bloated, similar to pregnancy.
• Pelvic Pain and Pressure: Compression of the bladder can lead to frequent urination (especially at night), while pressure on the bowel can cause constipation.
• Pain During Intercourse: Discomfort can occur due to compression in the pelvis.
• Impact on Fertility: Fibroids can block fallopian tubes, prevent the implantation of a fertilized egg, or contribute to recurrent miscarriages and preterm labor.

Modern Treatment and Management Options

Fortunately, advances in medical and surgical care now offer a wide range of treatment options. Management depends on symptoms, severity, and a woman’s fertility goals.

Medical Management

For mild symptoms, over-the-counter medications like ibuprofen can ease discomfort. For heavy bleeding, hormonal options are often effective:

• Hormonal Contraceptives: Oral contraceptives, vaginal rings, and hormonal IUDs can reduce bleeding and improve anemia. (Note: Copper IUDs are not recommended as they can worsen bleeding).
• Other Medications: Tranexamic acid can reduce bleeding during menstruation, while GnRH antagonists can shrink fibroids temporarily.

Minimally Invasive Procedures

When medication isn’t enough, these procedures offer effective relief:

• Uterine Artery Embolization (UAE): A radiologist blocks the blood flow to the fibroids, causing them to shrink. This procedure avoids major surgery and allows for a quick recovery.
• Radiofrequency Ablation: Uses heat to shrink fibroids over several months.
• Hysteroscopic Resection: A surgeon shaves fibroids from inside the uterine cavity without any skin incisions.

Surgical Options

Surgery remains an important option, especially for severe symptoms or fertility concerns:

• Myomectomy: The surgical removal of fibroids while preserving the uterus. This is the preferred option for women who wish to retain their fertility. It can now be performed with minimally invasive laparoscopic or robotic techniques.
• Hysterectomy: The complete removal of the uterus. This is considered a last resort for women who do not wish to have children in the future.

Emerging Treatments

Focused ultrasound surgery is an emerging treatment available in only a few centers.

Using MRI guidance, this non-invasive procedure directs ultrasound beams through the skin to heat and destroy fibroid tissue without damaging surrounding areas.

Find Your Path Forward at Ferny Fertility

Uterine fibroids can be a challenging and disruptive condition, but you don’t have to navigate it alone. The best approach depends on your unique symptoms, your overall health, and your future family-building goals.

The expert team at Ferny Fertility in Manhattan is here to provide a compassionate, personalized approach to your care. We can help you understand your options and create a treatment plan that aligns with your life.

Ready to take control of your health? Schedule a consultation with us today.

This article is adapted from the original piece by Mohammed Nizam, a Robotic Gynecologic Surgeon, and Neil Resnick, an Interventional Radiologist.